Literature DB >> 26437065

Diffuse large B-cell lymphoma: is salvage possible after failure of second-line treatment?

A Bazarbachi1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26437065     DOI： 10.1038/bmt.2015.225

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.

Authors:  E Van Den Neste; N Schmitz; N Mounier; D Gill; D Linch; M Trneny; N Milpied; J Radford; N Ketterer; O Shpilberg; U Dührsen; D Ma; J Brière; C Thieblemont; G Salles; C H Moskowitz; B Glass; C Gisselbrecht
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

2.  Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Authors:  T Philip; C Guglielmi; A Hagenbeek; R Somers; H Van der Lelie; D Bron; P Sonneveld; C Gisselbrecht; J Y Cahn; J L Harousseau
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

3.  Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.

Authors:  Christian Gisselbrecht; Norbert Schmitz; Nicolas Mounier; Devinder Singh Gill; David C Linch; Marek Trneny; Andre Bosly; Noel J Milpied; John Radford; Nicolas Ketterer; Ofer Shpilberg; Ulrich Dührsen; Hans Hagberg; David D Ma; Andreas Viardot; Ray Lowenthal; Josette Brière; Gilles Salles; Craig H Moskowitz; Bertram Glass
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544
  3 in total
  1 in total

1.  Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma.

Authors:  Nana Ping; Changju Qu; Mengyun Li; Liqing Kang; Danqin Kong; Xiaochen Chen; Qian Wu; Fan Xia; Lei Yu; Hong Yao; Lingzhi Yan; Depei Wu; Zhengming Jin
Journal:  Ann Transl Med       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.